 | • レポートコード：MRC309Z7829 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の粗ヘパリンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の粗ヘパリン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 粗ヘパリンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 粗ヘパリン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・豚腸粘膜ヘパリン、牛ヘパリン 他 用途別セグメント ・UFH、LMWH 主要な市場プレーヤー ・Bioiberica、Shenzhen Hepalink、Sanofi、Nanjing King-friend、Fengrun Biological Technology、Aspen Oss、Hebei Changshan Biochemical、Changzhou Qianhong、Hepac (Darling Ingredients)、Huaian MDC Pharmaceutical、Yantai Dongcheng Biochemicals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、粗ヘパリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な粗ヘパリンメーカーの企業概要、2019年～2022年までの粗ヘパリンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な粗ヘパリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別粗ヘパリンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの粗ヘパリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での粗ヘパリン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および粗ヘパリンの産業チェーンを掲載しています。 ・第14、15章では、粗ヘパリンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 粗ヘパリンの概要 - 種類別分析（2018年vs2022年vs2029年）：豚腸粘膜ヘパリン、牛ヘパリン 他 - 用途別分析（2018年vs2022年vs2029年）：UFH、LMWH - 世界の粗ヘパリン市場規模・予測 - 世界の粗ヘパリン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bioiberica、Shenzhen Hepalink、Sanofi、Nanjing King-friend、Fengrun Biological Technology、Aspen Oss、Hebei Changshan Biochemical、Changzhou Qianhong、Hepac (Darling Ingredients)、Huaian MDC Pharmaceutical、Yantai Dongcheng Biochemicals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：豚腸粘膜ヘパリン、牛ヘパリン 他 ・用途別分析2018年-2029年：UFH、LMWH ・粗ヘパリンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・粗ヘパリンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・粗ヘパリンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・粗ヘパリンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・粗ヘパリンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Crude Heparin market size was valued at USD 3555 million in 2022 and is forecast to a readjusted size of USD 5318.6 million by 2029 with a CAGR of 5.9% during review period.
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology. The top three players hold a share about 30%. The global crude heparin products are mainly produced in Europe and China. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 90%.
The Global Info Research report includes an overview of the development of the Crude Heparin industry chain, the market status of UFH (Pig Intestine Mucosa Heparin, Bovine Heparin and Others), LMWH (Pig Intestine Mucosa Heparin, Bovine Heparin and Others), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Crude Heparin.
Regionally, the report analyzes the Crude Heparin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Crude Heparin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Crude Heparin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Crude Heparin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Pig Intestine Mucosa Heparin, Bovine Heparin and Others).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Crude Heparin market.
Regional Analysis: The report involves examining the Crude Heparin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Crude Heparin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Crude Heparin:
Company Analysis: Report covers individual Crude Heparin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Crude Heparin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (UFH, LMWH).
Technology Analysis: Report covers specific technologies relevant to Crude Heparin. It assesses the current state, advancements, and potential future developments in Crude Heparin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Crude Heparin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Crude Heparin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Market segment by Application
UFH
LMWH
Major players covered
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Crude Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Crude Heparin, with price, sales, revenue and global market share of Crude Heparin from 2018 to 2023.
Chapter 3, the Crude Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crude Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Crude Heparin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Crude Heparin.
Chapter 14 and 15, to describe Crude Heparin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Crude Heparin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Crude Heparin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pig Intestine Mucosa Heparin
1.3.3 Bovine Heparin and Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Crude Heparin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 UFH
1.4.3 LMWH
1.5 Global Crude Heparin Market Size & Forecast
1.5.1 Global Crude Heparin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Crude Heparin Sales Quantity (2018-2029)
1.5.3 Global Crude Heparin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bioiberica
2.1.1 Bioiberica Details
2.1.2 Bioiberica Major Business
2.1.3 Bioiberica Crude Heparin Product and Services
2.1.4 Bioiberica Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bioiberica Recent Developments/Updates
2.2 Shenzhen Hepalink
2.2.1 Shenzhen Hepalink Details
2.2.2 Shenzhen Hepalink Major Business
2.2.3 Shenzhen Hepalink Crude Heparin Product and Services
2.2.4 Shenzhen Hepalink Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shenzhen Hepalink Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Crude Heparin Product and Services
2.3.4 Sanofi Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Nanjing King-friend
2.4.1 Nanjing King-friend Details
2.4.2 Nanjing King-friend Major Business
2.4.3 Nanjing King-friend Crude Heparin Product and Services
2.4.4 Nanjing King-friend Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Nanjing King-friend Recent Developments/Updates
2.5 Fengrun Biological Technology
2.5.1 Fengrun Biological Technology Details
2.5.2 Fengrun Biological Technology Major Business
2.5.3 Fengrun Biological Technology Crude Heparin Product and Services
2.5.4 Fengrun Biological Technology Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Fengrun Biological Technology Recent Developments/Updates
2.6 Aspen Oss
2.6.1 Aspen Oss Details
2.6.2 Aspen Oss Major Business
2.6.3 Aspen Oss Crude Heparin Product and Services
2.6.4 Aspen Oss Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aspen Oss Recent Developments/Updates
2.7 Hebei Changshan Biochemical
2.7.1 Hebei Changshan Biochemical Details
2.7.2 Hebei Changshan Biochemical Major Business
2.7.3 Hebei Changshan Biochemical Crude Heparin Product and Services
2.7.4 Hebei Changshan Biochemical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hebei Changshan Biochemical Recent Developments/Updates
2.8 Changzhou Qianhong
2.8.1 Changzhou Qianhong Details
2.8.2 Changzhou Qianhong Major Business
2.8.3 Changzhou Qianhong Crude Heparin Product and Services
2.8.4 Changzhou Qianhong Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Changzhou Qianhong Recent Developments/Updates
2.9 Hepac (Darling Ingredients)
2.9.1 Hepac (Darling Ingredients) Details
2.9.2 Hepac (Darling Ingredients) Major Business
2.9.3 Hepac (Darling Ingredients) Crude Heparin Product and Services
2.9.4 Hepac (Darling Ingredients) Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hepac (Darling Ingredients) Recent Developments/Updates
2.10 Huaian MDC Pharmaceutical
2.10.1 Huaian MDC Pharmaceutical Details
2.10.2 Huaian MDC Pharmaceutical Major Business
2.10.3 Huaian MDC Pharmaceutical Crude Heparin Product and Services
2.10.4 Huaian MDC Pharmaceutical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Huaian MDC Pharmaceutical Recent Developments/Updates
2.11 Yantai Dongcheng Biochemicals
2.11.1 Yantai Dongcheng Biochemicals Details
2.11.2 Yantai Dongcheng Biochemicals Major Business
2.11.3 Yantai Dongcheng Biochemicals Crude Heparin Product and Services
2.11.4 Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates
3 Competitive Environment: Crude Heparin by Manufacturer
3.1 Global Crude Heparin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Crude Heparin Revenue by Manufacturer (2018-2023)
3.3 Global Crude Heparin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Crude Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Crude Heparin Manufacturer Market Share in 2022
3.4.2 Top 6 Crude Heparin Manufacturer Market Share in 2022
3.5 Crude Heparin Market: Overall Company Footprint Analysis
3.5.1 Crude Heparin Market: Region Footprint
3.5.2 Crude Heparin Market: Company Product Type Footprint
3.5.3 Crude Heparin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Crude Heparin Market Size by Region
4.1.1 Global Crude Heparin Sales Quantity by Region (2018-2029)
4.1.2 Global Crude Heparin Consumption Value by Region (2018-2029)
4.1.3 Global Crude Heparin Average Price by Region (2018-2029)
4.2 North America Crude Heparin Consumption Value (2018-2029)
4.3 Europe Crude Heparin Consumption Value (2018-2029)
4.4 Asia-Pacific Crude Heparin Consumption Value (2018-2029)
4.5 South America Crude Heparin Consumption Value (2018-2029)
4.6 Middle East and Africa Crude Heparin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Crude Heparin Sales Quantity by Type (2018-2029)
5.2 Global Crude Heparin Consumption Value by Type (2018-2029)
5.3 Global Crude Heparin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Crude Heparin Sales Quantity by Application (2018-2029)
6.2 Global Crude Heparin Consumption Value by Application (2018-2029)
6.3 Global Crude Heparin Average Price by Application (2018-2029)
7 North America
7.1 North America Crude Heparin Sales Quantity by Type (2018-2029)
7.2 North America Crude Heparin Sales Quantity by Application (2018-2029)
7.3 North America Crude Heparin Market Size by Country
7.3.1 North America Crude Heparin Sales Quantity by Country (2018-2029)
7.3.2 North America Crude Heparin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Crude Heparin Sales Quantity by Type (2018-2029)
8.2 Europe Crude Heparin Sales Quantity by Application (2018-2029)
8.3 Europe Crude Heparin Market Size by Country
8.3.1 Europe Crude Heparin Sales Quantity by Country (2018-2029)
8.3.2 Europe Crude Heparin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Crude Heparin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Crude Heparin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Crude Heparin Market Size by Region
9.3.1 Asia-Pacific Crude Heparin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Crude Heparin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Crude Heparin Sales Quantity by Type (2018-2029)
10.2 South America Crude Heparin Sales Quantity by Application (2018-2029)
10.3 South America Crude Heparin Market Size by Country
10.3.1 South America Crude Heparin Sales Quantity by Country (2018-2029)
10.3.2 South America Crude Heparin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Crude Heparin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Crude Heparin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Crude Heparin Market Size by Country
11.3.1 Middle East & Africa Crude Heparin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Crude Heparin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Crude Heparin Market Drivers
12.2 Crude Heparin Market Restraints
12.3 Crude Heparin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Crude Heparin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Crude Heparin
13.3 Crude Heparin Production Process
13.4 Crude Heparin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Crude Heparin Typical Distributors
14.3 Crude Heparin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer